Up a level |
Sharman, Jeff P, Coutre, Steven E, Furman, Richard R, Cheson, Bruce D, Pagel, John M, Hillmen, Peter, Barrientos, Jacqueline C, Zelenetz, Andrew D, Kipps, Thomas J, Flinn, Ian W et al (show 14 more authors)
(2019)
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia.
Journal of Clinical Oncology, 37 (16).
pp. 1391-1402.
Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael and Furman, Richard R
(2020)
Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial.
HAEMATOLOGICA, 105 (10).
E519-E522.
Bloehdorn, Johannes, Braun, Andrejs, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz et al (show 24 more authors)
(2021)
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
NATURE COMMUNICATIONS, 12 (1).
5395-.
Kreuzer, Karl-Anton, Furman, Richard R, Stilgenbauer, Stephan, Dubowy, Ronald L, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara et al (show 4 more authors)
(2020)
The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab.
Leukemia, 34 (1).
pp. 296-300.
Braun, Fabian, Rinschen, Markus, Buchner, Denise, Bohl, Katrin, Plagmann, Ingo, Bachurski, Daniel, Richard Späth, Martin, Antczak, Philipp ORCID: 0000-0001-9600-7757, Göbel, Heike, Klein, Corinna et al (show 12 more authors)
(2020)
The proteomic landscape of small urinary extracellular vesicles during kidney transplantation.
Journal of Extracellular Vesicles, 10 (1).